Datopotamab Deruxtecan Improves Survival Over Chemotherapy in Patients with Previously Untreated, Locally Recurrent Inoperable or Metastatic TNBC By Ogkologos - April 28, 2026 87 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TROPION-Breast02 study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Η ΚΑΘΗΜΕΡΙΝΟΤΗΤΑ December 10, 2018 Finally Pregnant After Struggling With Infertility For Years, She Was Diagnosed... October 25, 2019 Adjusting to the Challenges of Life After Cancer: An Expert Perspective May 5, 2022 Hamlet Drug, Modeled After Protein In Breast Milk, Kills Tumor Cells... June 26, 2019 Load more HOT NEWS Breast Cancer Patients with Low Breast Density May Be More Likely... Marshall University Study Finds That Walnuts Suppress Breast Cancer Growth And... The Investigational PD1 Antibody, Tislelizumab, Shows Promise in Patients With Unresectable... Manageable Safety and Promising Activity of Neoadjuvant Pembrolizumab plus Vibostolimab, Pembrolizumab...
